2 fast growth ASX shares that could be buys in December 2021

Volpara is one of the ASX growth shares that could be compelling in December 2021.

| More on:
Mother and young children at doctors

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX growth shares increasing in size quickly could be contenders for an investor’s portfolio.

There is growing volatility in the ASX share market. This may open up some better value opportunities for people to find.

Share prices regularly change, but lower prices give the chance getting exposure to quality companies at the best prices.

Here are two of them:

Doctor Care Anywhere Group PLC (ASX: DOC)

Doctor Care Anywhere is a UK-based telehealth company that is committed to delivering the best possible patient experience and clinical care through digitally enabled, joined up, evidence-based pathways on its platform. It has relationships with health insurers, healthcare providers and corporate customers to connect with a range of telehealth services.

It also recently completed the acquisition of Australian telehealth and tele-mental provider GP2U Telehealth. This gives the business another avenue for growth and geographical diversification. The ASX growth share has also entered the self-pay market in the Republic of Ireland through its channel partner Boots.

It’s expecting to report 2021 revenue growth of at least 100% compared to FY20, excluding the acquisition.

The three months to 30 September 2021 saw growth with a number of metrics. Quarter on quarter revenue growth was 21.6% to AU$10.7 million. Consultations grew by 30.6% to 116,800 with over 65% of consultations delivered to returning patients.

Activated lives reached 603,200 during the quarter – up 8% quarter on quarter. An activated life is the total number of people who have signed up for Doctor Care Anywhere’s service and entered their personal details.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara describes itself as a health technology software company with an integrated platform which assists in the delivery of personalised breast care.

The ASX growth share grew its subscription revenue by 35% to NZ$11.8 million in the first half of FY22. Its revenue comes with a very high gross profit margin of 91.4%.

Its market share of women who have at least one Volpara product used on their image is around 34%.

Volpara says that its strategic commercial partnerships will help it achieve greater reach in not only genetic testing for breast cancer but expansion into the US lung cancer market where AI and software offer the prospect of saving many more lives.

It has partnered with a number of different organisations, including in lung, with RevealDx, Riverain Technologies, Natera and Invitae.

The company has a number of areas of focus for growth such as expanding the electronic health record (EHR) sales channel. It’s also working on building its data platform in a key effort to change from screening for detection to prevention.

It’s expecting to reach revenue of between NZ$25 million to NZ$26 million in this financial year.

Volpara management said the next few months is going to be “incredibly busy and exciting” as it heads to Chicago for the large radiology conference RSNA. The third and fourth quarters of the year are traditionally the biggest quarters for the business.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Doctor Care Anywhere Group PLC and VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A man sees some good news on his phone and gives a little cheer.
Growth Shares

2 excellent ASX growth shares to buy now according to brokers

Check out these excellent ASX growth shares...

Read more »

A man in his 30s holds his computer underneath and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Growth Shares

Brokers just rated these ASX 200 shares as buys in August

Pinnacle and Domain are two businesses worth investing in, according to experts.

Read more »

A man in his 30s holds his computer underneath and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Growth Shares

2 stellar ASX 200 shares that brokers rate as buys

Here are two high quality ASX 200 shares...

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Growth Shares

2 excellent ASX growth shares to buy – experts

Analysts rate these growth shares very highly...

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Growth Shares

Experts name 2 ASX growth shares to buy

Here are two growth shares that could be in the buy zone now...

Read more »

An attractive woman sits at her computer with her chin resting on her hand as she contemplates the WAM Alternative Assets listed investment company as a potential investment
Growth Shares

I rate these top ASX growth shares as buys in August

The iShares S&P 500 ETF is one idea that looks compelling for the long-term.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Growth Shares

Broker names 2 ASX 200 shares to buy in August

These ASX 200 shares could be in the buy zone...

Read more »

Surge in ASX share price represented by happy woman pointing to her big smile
Growth Shares

Here are 3 stellar ASX growth shares analysts are tipping as buys

Here are three growth shares to buy...

Read more »